K. Bailey

发表

Electrocardiographic prediction of myocardial area at risk.

R. Gibbons, I. Clements, P. Pellikka, 1991, Mayo Clinic proceedings.

Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction

K. Bailey, R. Gibbons, R. Rodeheffer, 1993, The Lancet.

Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: implications for the design of randomized trials of acute intervention.

R. Gibbons, D. Hodge, M. Hopfenspirger, 1994, Journal of the American College of Cardiology.

Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling.

K. Bailey, C. Zoccali, S. Signorelli, 2001, Mayo Clinic proceedings.

The effect of systemic hypertension on exercise tomographic thallium-201 imaging in the absence of electrocardiographic left ventricular hypertrophy.

R. Gibbons, T. Miller, T. Christian, 1993, American heart journal.

Intravenous adenosine and lidocaine in patients with acute myocardial infarction.

K. Bailey, R. Gibbons, D. Hodge, 1998, American heart journal.

Determinants of pulmonary hypertension in left ventricular dysfunction.

M. Enriquez-Sarano, J. Seward, K. Bailey, 1997, Journal of the American College of Cardiology.

Clinical criteria and biochemical markers for the detection of systolic dysfunction.

K. Bailey, M. Redfield, J. Burnett, 2000, Journal of cardiac failure.

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

K. Bailey, B. Gersh, R. Gibbons, 1993, The New England journal of medicine.

Quantitative measures of regional asynergy add independent prognostic information to left ventricular ejection fraction in patients with prior myocardial infarction.

R. Gibbons, T. Miller, A. Weissler, 1997, American heart journal.

Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging.

K. Bailey, D. Berman, R. Gibbons, 1999, Circulation.

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

K. Bailey, K. Nakao, R. Nishimura, 1996, Hypertension.

Worsening left ventricular performance on serial exercise radionuclide angiography does not identify high-risk patients.

R. Gibbons, T. Miller, H. Chaliki, 1997, Mayo Clinic proceedings.

Telemedicine consultations in congenital heart disease: assessment of advanced technical capabilities.

M A Wondrow, J F Breen, J. Breen, 1999, Mayo Clinic proceedings.